Neoadjuvant chemotherapy in advanced ovarian cancer: what is the optimal number of cycles?

被引：0
|
作者：
Ltaief, Sarra Ben [1 ]
Bouhani, Malek [1 ]
Houissa, Iness [1 ]
Sakhri, Saida [1 ]
Bouaziz, Hanen [1 ]
Dhiab, Tarek Ben [1 ]
机构：
[1] Inst Salah Aziez Tunisia, Surg Oncol, Tunis Ville, Tunisia
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2024年 / 34卷 / SUPPL_3期
关键词：
D O I：
10.1136/ijgc-2024-IGCS.344
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EV225
引用
收藏
页码：A200 / A200
页数：1
相关论文
共 50 条
  • [1] Neoadjuvant chemotherapy in advanced epithelial ovarian cancer: Is the number of preoperative cycles important?
    Cantu de Leon, D.
    Gallardo-Alvarado, L. N.
    Salcedo-Hernandez, R. A.
    Perez-Montiel, D.
    Ramirez, R.
    Barquet-Munoz, S. A.
    Perez Quintanilla, M.
    Rivera-Buendia, F.
    Del Real, S.
    GYNECOLOGIC ONCOLOGY, 2020, 159 : 122 - 123
  • [2] Neoadjuvant chemotherapy without a fixed number of cycles in advanced ovarian cancer not candidates for optimal primary surgery.
    Mendiola, Cesar
    Manneh, Ray
    Pascual, Tomas
    De Velasco, Guillermo
    Vega, Estela
    Manso, Luis
    Ghanem, Ismael
    Ciruelos, Eva M.
    Seoane, J.
    Cortes-Funes, Hernan
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [3] Evaluation of Optimal Number of Neoadjuvant Chemotherapy Cycles and Cytoreductive Surgery in Women with Ovarian Cancer
    Hassani, Shahrzad Sheikh
    Moradpanah, Somayeh
    Akhavan, Setare
    Mousavi, Azamsadat
    Zamani, Narges
    Rezayof, Elahe
    INDIAN JOURNAL OF GYNECOLOGIC ONCOLOGY, 2024, 22 (01)
  • [4] Evaluation of Optimal Number of Neoadjuvant Chemotherapy Cycles and Cytoreductive Surgery in Women with Ovarian Cancer
    Shahrzad Sheikh Hassani
    Somayeh Moradpanah
    Setare Akhavan
    Azamsadat Mousavi
    Narges Zamani
    Elahe Rezayof
    Indian Journal of Gynecologic Oncology, 2024, 22
  • [5] Prolongation of Neoadjuvant Chemotherapy before Surgery: Seeking the Optimal Number of Cycles in Serous Ovarian Cancer
    Minareci, Yagmur
    Sozen, Hamdullah
    Ak, Naziye
    Tosun, Ozgur A.
    Saip, Pinar
    Salihoglu, M. Yavuz
    Topuz, Samet
    CHEMOTHERAPY, 2022, 67 (01) : 1 - 11
  • [6] 3-4 Cycles versus 6 Cycles Neoadjuvant Chemotherapy in Advanced-Stage Epithelial Ovarian Cancer: Survival Is Not Determined by the Number of Neoadjuvant Chemotherapy Cycles
    Bese, Tugan
    Bicer, Elifnur
    Kayan, Basak Ozge
    Cebi, Sait Sukru
    Acikgoz, Abdullah Serdar
    Turna, Hande
    Demirkiran, Fuat
    CHEMOTHERAPY, 2024, 69 (02) : 122 - 131
  • [7] Survival impact of histological response to neoadjuvant chemotherapy according to number of cycles in patients with advanced ovarian cancer
    Betrian, Sarah
    Angeles, Martina Aida
    Gil Moreno, Antonio
    Cabarrou, Bastien
    Deslandres, Marion
    Ferron, Gwenael
    Mery, Eliane
    Floquet, Anne
    Guyon, Frederic
    Perez-Benavente, Assumpcio
    Spagnolo, Emanuela
    Rychlik, Agnieszka
    Gladieff, Laurence
    Gutierrez, Alicia Hernandez
    Martinez, Alejandra
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2022, 32 (08) : 967 - 974
  • [8] What is the optimal number of neoadjuvant chemotherapy cycles for resectable colorectal liver oligometastases?
    Chen, Qichen
    Li, Xingchen
    Zhao, Jianjun
    Bi, Xinyu
    Li, Zhiyu
    Huang, Zhen
    Zhang, Yefan
    Zhou, Jianguo
    Zhao, Hong
    Cai, Jianqiang
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (01)
  • [9] Impact of neoadjuvant chemotherapy and postoperative adjuvant chemotherapy cycles in patients with advanced ovarian cancer
    Chung, Y. S.
    Lee, J. Y.
    Nam, E. J.
    Kim, S. K.
    Kim, S. W.
    Kim, Y. T.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 : 662 - 662
  • [10] Impact of neoadjuvant chemotherapy and postoperative adjuvant chemotherapy cycles in patients with advanced ovarian cancer
    Chung, Y. S.
    Eoh, K. J.
    Lee, I.
    Lee, J. Y.
    Nam, E. J.
    Kim, S.
    Kim, S. W.
    Kim, Y. T.
    GYNECOLOGIC ONCOLOGY, 2017, 145 : 101 - 102
12345